202 related articles for article (PubMed ID: 20800559)
1. Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.
Bayani J; Marrano P; Graham C; Zheng Y; Li L; Katsaros D; Lassus H; Butzow R; Squire JA; Diamandis EP
Mol Oncol; 2011 Feb; 5(1):48-60. PubMed ID: 20800559
[TBL] [Abstract][Full Text] [Related]
2. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.
Bayani J; Kuzmanov U; Saraon P; Fung WA; Soosaipillai A; Squire JA; Diamandis EP
Clin Chem; 2013 Jan; 59(1):296-305. PubMed ID: 23136250
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer.
Bayani J; Paliouras M; Planque C; Shan SJ; Graham C; Squire JA; Diamandis EP
Mol Oncol; 2008 Oct; 2(3):250-60. PubMed ID: 19383346
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4.
Harvey TJ; Hooper JD; Myers SA; Stephenson SA; Ashworth LK; Clements JA
J Biol Chem; 2000 Dec; 275(48):37397-406. PubMed ID: 10969073
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease.
Skirnisdottir I; Mayrhofer M; Rydåker M; Akerud H; Isaksson A
BMC Cancer; 2012 Sep; 12():407. PubMed ID: 22967087
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
[TBL] [Abstract][Full Text] [Related]
7. Parallel overexpression of seven kallikrein genes in ovarian cancer.
Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
[TBL] [Abstract][Full Text] [Related]
8. Integrated genomic characterization of the kallikrein gene locus in cancer.
Girgis AH; Bui A; White NM; Yousef GM
Anticancer Res; 2012 Mar; 32(3):957-63. PubMed ID: 22399617
[TBL] [Abstract][Full Text] [Related]
9. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions.
Clements J; Hooper J; Dong Y; Harvey T
Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672
[TBL] [Abstract][Full Text] [Related]
10. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
[TBL] [Abstract][Full Text] [Related]
11. The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation.
Yousef GM; Diamandis EP
J Biol Chem; 1999 Dec; 274(53):37511-6. PubMed ID: 10608802
[TBL] [Abstract][Full Text] [Related]
12. A computational analysis of the genetic and transcript diversity at the kallikrein locus.
Lai J; An J; Srinivasan S; Clements JA; Batra J
Biol Chem; 2016 Dec; 397(12):1307-1313. PubMed ID: 27289002
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
Shan SJ; Scorilas A; Katsaros D; Diamandis EP
Br J Cancer; 2007 Jan; 96(2):362-72. PubMed ID: 17242704
[TBL] [Abstract][Full Text] [Related]
15. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4.
Stephenson SA; Verity K; Ashworth LK; Clements JA
J Biol Chem; 1999 Aug; 274(33):23210-4. PubMed ID: 10438493
[TBL] [Abstract][Full Text] [Related]
16. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.
Gunn S; Yeh IT; Lytvak I; Tirtorahardjo B; Dzidic N; Zadeh S; Kim J; McCaskill C; Lim L; Gorre M; Mohammed M
BMC Cancer; 2010 Jul; 10():396. PubMed ID: 20667129
[TBL] [Abstract][Full Text] [Related]
17. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
[TBL] [Abstract][Full Text] [Related]
18. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
19. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Obiezu CV; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Rigault de la Longrais IA; Arisio R; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2380-6. PubMed ID: 11489816
[TBL] [Abstract][Full Text] [Related]
20. The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9).
Yousef GM; Diamandis EP
Genomics; 2000 Apr; 65(2):184-94. PubMed ID: 10783266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
